SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,583.62 -115.24
(-0.25%)

Dow Jones

6,653.27 -40.35
(-0.60%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

92.29 0.37
(0.40%)

EUR-INR

106.44 -0.15
(-0.14%)

GBP-INR

123.36 -0.03
(-0.03%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.35

777.21

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

mahindra & mahindra ltd

Maha Rashtra Apex Corporation reports consolidated net loss of Rs 30.69 crore in the September 2025 quarter

Nov 14,2025

Net Loss of Maha Rashtra Apex Corporation reported to Rs 30.69 crore in the quarter ended September 2025 as against net loss of Rs 7.97 crore during the previous quarter ended September 2024. Sales declined 87.50% to Rs 0.06 crore in the quarter ended September 2025 as against Rs 0.48 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.06	0.48	-88
OPM %	-51666.67	-1835.42	-
PBDT	-30.73	-8.63	-256
PBT	-30.74	-8.64	-256
NP	-30.69	-7.97	-285

74,563.92 -1,470.50 ( -1.93%)

46,583.62 -115.24 (-0.25%)

6,653.27 -40.35 (-0.60%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

92.29 0.37 (0.40%)

106.44 -0.15 (-0.14%)

123.36 -0.03 (-0.03%)

0.58 0.00 (0.05%)